Watts Peter

Avg. Two Year Performance

258% Avg. Purchase Return
89% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return6%(< 1%)43%(15%)258%
Purchase Success Rate1 of 10 of 11 of 10 of 11 of 1
Average Sale Return----------
Sale Success Rate----------

Alpharma, Inc.

Drugs » Drug Manufacturers - Other

EVP, HR and Communications:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--